title: Best practices for reporting pathology interpretations within GLP toxicology studies.
authors.affiliation: Pfizer Inc., Groton, Connecticut 06340, USA. dan.g.morton@pfizer.com
authors.forename: Daniel
authors.initials: D
authors.lastname: Morton
authors.forename: Ramon K
authors.initials: RK
authors.lastname: Kemp
authors.forename: Sabine
authors.initials: S
authors.lastname: Francke-Carroll
authors.forename: Karl
authors.initials: K
authors.lastname: Jensen
authors.forename: Jeffrey
authors.initials: J
authors.lastname: McCartney
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Monticello
authors.forename: Richard
authors.initials: R
authors.lastname: Perry
authors.forename: Olga
authors.initials: O
authors.lastname: Pulido
authors.forename: Nigel
authors.initials: N
authors.lastname: Roome
authors.forename: Ken
authors.initials: K
authors.lastname: Schafer
authors.forename: Rani
authors.initials: R
authors.lastname: Sellers
authors.forename: Paul W
authors.initials: PW
authors.lastname: Snyder
mesh_terms: D019985:Benchmarking; D035843:Biomedical Research; D006801:Humans; D007753:Laboratories; D010336:Pathology / Q000379:methods / Q000592:standards*; D010380:Peer Review; D011361:Professional Competence; D012958:Societies, Scientific; D014116:Toxicology / Q000379:methods / Q000592:standards*; D014956:Writing / Q000592:standards*